Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,308,512
  • Shares Outstanding, K 30,162
  • Annual Sales, $ 12,730 K
  • Annual Income, $ -295,160 K
  • 60-Month Beta 2.57
  • Price/Sales 403.33
  • Price/Cash Flow N/A
  • Price/Book 8.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.13
  • Number of Estimates 8
  • High Estimate 1.68
  • Low Estimate -1.80
  • Prior Year -1.26
  • Growth Rate Est. (year over year) +89.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
167.91 +4.82%
on 06/17/19
188.76 -6.76%
on 05/22/19
+0.95 (+0.54%)
since 05/17/19
3-Month
151.32 +16.31%
on 04/18/19
196.00 -10.20%
on 05/07/19
+7.39 (+4.38%)
since 03/18/19
52-Week
90.14 +95.25%
on 12/27/18
196.00 -10.20%
on 05/07/19
+25.78 (+17.16%)
since 06/18/18

Most Recent Stories

More News
They Meet, We Rally

They Meet, We Rally

ACCO : 7.94 (+3.66%)
WW : 20.92 (+0.97%)
CF : 47.22 (+1.48%)
ILMN : 347.85 (-0.93%)
GWPH : 176.00 (+3.33%)
IPHI : 49.06 (+4.90%)
ALGN : 290.06 (+0.48%)
CMTL : 28.32 (+4.31%)
UIS : 9.43 (+3.97%)
SPWR : 10.15 (+22.58%)
BA : 373.96 (+5.37%)
CRM : 150.59 (+0.20%)
4 Stocks to Buy for Solid Earnings Acceleration

Studies show that a majority of successful stocks see acceleration in earnings before an uptick in the stock price.

COO : 324.19 (-0.09%)
BE : 12.07 (+2.37%)
TCEHY : 43.8300 (+4.56%)
GWPH : 176.00 (+3.33%)
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Canopy Growth, Aurora Cannabis and Hexo

The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Canopy Growth, Aurora Cannabis and Hexo

ACB : 7.56 (-0.53%)
HEXO : 5.55 (+0.73%)
GWPH : 176.00 (+3.33%)
CGC : 42.04 (+0.41%)
4 CBD Stocks to Win Big in June

Analysts estimate that nearly 65 million Americans have tried CBD and 63% have found it effective. What's more, CBD is a growing industry with sales expected to rise 55% to $648 million in 2019.

ACB : 7.56 (-0.53%)
HEXO : 5.55 (+0.73%)
GWPH : 176.00 (+3.33%)
CGC : 42.04 (+0.41%)
FDA to Hold First Public Hearing on Cannabis: 5 Likely Gainers

Several CBD manufacturers, researchers, farmers and retailers have urged the regulatory authority to allow the use of cannabis.

ACB : 7.56 (-0.53%)
CRON : 15.71 (-0.88%)
GWPH : 176.00 (+3.33%)
SMG : 98.17 (+1.34%)
CGC : 42.04 (+0.41%)
Disruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, Edibles

Fueled by an explosion of CBD-infused edibles, billion-dollar projections for the CBD market may even be conservative.

ACB : 7.56 (-0.53%)
ACB.TO : 10.14 (-0.20%)
TLRY : 41.05 (+1.58%)
MRMD : 2.2500 (+7.66%)
GWPH : 176.00 (+3.33%)
LXRP : 0.8700 (unch)
LXX.CN : 1.180 (+2.61%)
Is GW Pharmaceuticals (GWPH) Stock Outpacing Its Medical Peers This Year?

Is (GWPH) Outperforming Other Medical Stocks This Year?

GWPH : 176.00 (+3.33%)
GW Pharmaceuticals PLC (GWPH) Is Up 1.6% in One Week: What You Should Know

Does GW Pharmaceuticals PLC (GWPH) have what it takes to be a top stock pick for momentum investors? Let's find out.

GWPH : 176.00 (+3.33%)
Marijuana ETFs Head-to-Head

Here is what investors need to know about cannabis investing and the two ETFs that provide exposure to the space.

ACB : 7.56 (-0.53%)
YOLO : 23.03 (+0.83%)
CRON : 15.71 (-0.88%)
TLRY : 41.05 (+1.58%)
GWPH : 176.00 (+3.33%)
MJ : 31.55 (+0.06%)
CGC : 42.04 (+0.41%)
The Zacks Analyst Blog Highlights: Scott's Miracle Grow, GW Pharmaceuticals, Canopy Growth, Tilray and Aurora Cannabis

The Zacks Analyst Blog Highlights: Scott's Miracle Grow, GW Pharmaceuticals, Canopy Growth, Tilray and Aurora Cannabis

ACB : 7.56 (-0.53%)
TLRY : 41.05 (+1.58%)
GWPH : 176.00 (+3.33%)
SMG : 98.17 (+1.34%)
CGC : 42.04 (+0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade GWPH with:

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 181.40
1st Resistance Point 178.70
Last Price 176.00
1st Support Level 171.94
2nd Support Level 167.88

See More

52-Week High 196.00
Last Price 176.00
Fibonacci 61.8% 155.56
Fibonacci 50% 143.07
Fibonacci 38.2% 130.58
52-Week Low 90.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar